Comparative evaluation of intravenous versus intranasal dexmedetomidine on emergence delirium and hemodynamics in pediatric patients undergoing adenotonsillectomy: a randomized controlled trial
Vergleich von intravenösem versus intranasalem Dexmedetomidin auf Emergenzdelir und Hämodynamik bei pädiatrischen Patient:innen nach Adenotonsillektomie: randomisierte kontrollierte Studie
Frontiers in Pharmacology · 30.01.2025 · 16
DOI: 10.3389/fphar.2025.1543344 ↗Auf einen Blick
Bei 139 Kindern nach Adenotonsillektomie senkten intravenöses und intranasales Dexmedetomidin das Emergenzdelir und die Schmerzen gegenüber Kontrolle. Intranasal war die Hämodynamik stabiler und die Analgesie/Sedierung länger.
Fragestellung
Wie wirken intravenöses im Vergleich zu intranasalem Dexmedetomidin auf Emergenzdelir und Hämodynamik bei Kindern nach Adenotonsillektomie?
Methode
Randomisierte kontrollierte Studie mit 139 Kindern, 3–10 Jahre; Zuteilung zu intravenösem Dexmedetomidin, intranasalem Dexmedetomidin oder Kochsalz nach Narkoseeinleitung.
Ergebnisse
Der höchste PAED- und Schmerzscore war in beiden Dexmedetomidin-Gruppen in den ersten 30 min niedriger als in der Kontrollgruppe. Zwischen IV- und IN-Gruppe kein signifikanter Unterschied; IN besser bei PAED nach 2 h und Schmerzen nach 2, 4, 6 h.
Schlussfolgerung der Autor:innen
Intravenöses und intranasales Dexmedetomidin nach Narkoseeinleitung verbesserten Emergenzdelir und Schmerzintensität. Intranasal bot stabilere Hämodynamik sowie längere Analgesie und Sedierung als intravenös.
Kernaussagen
- PAED- und Schmerzscore niedriger als unter Kochsalz
- Zwischen IV- und IN-Gabe zunächst kein signifikanter Unterschied
- Intranasal: stabilere Hämodynamik und längere Wirkung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Pharmacology, online erschienen am 30.01.2025. Verfasst von Chenxu Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Delir
Abstract (Originalsprache)
Background
Dexmedetomidine effectively prevents emergence delirium in children. However, intravenous dexmedetomidine is frequently associated with hemodynamic instability and delayed recovery. Intranasal dexmedetomidine has been proposed as a method of reducing these side effects. This study aimed to evaluate the effects of intranasal versus intravenous dexmedetomidine on emergence recovery and hemodynamics in children undergoing adenotonsillectomy.
Methods
A total of 139 children, aged 3–10 years, who were scheduled for elective adenotonsillectomy were randomly assigned to receive intravenous dexmedetomidine (IV DEX group) or intranasal dexmedetomidine (IN DEX group), or saline (control group) after anesthesia induction. The primary outcome was the highest score on the pediatric anesthesia emergence delirium (PAED) score during the first 30 min after awakening. Secondary outcomes included the perioperative blood pressure and heart rate, time to awakening, postoperative pain score, and length of post-anesthesia care unit (PACU) stay.
Results
The highest PAED and pain scores were significantly lower in the IV and IN DEX groups than those in the control group during the first 30 min after awakening. However, no significant differences were observed between the IV and IN DEX groups. Notably, patients in the IN DEX group exhibited a significantly lower PAED score at 2 h and lower pain scores at 2, 4, and 6 h postoperatively than those in the IV DEX group. Patients in the IV DEX group exhibited a significantly longer awakening time and length of PACU stay than those in the IN DEX and control groups. In the IV DEX group, the heart rate was significantly lower perioperatively than at baseline, while this effect was not observed in the IN DEX group.
Conclusion
Both intravenous and intranasal administration of dexmedetomidine after induction of anesthesia effectively improved emergence delirium and pain intensity in children undergoing adenotonsillectomy. Intranasal administration of dexmedetomidine provided more stable hemodynamics and more prolonged analgesia and sedation than intravenous infusion of dexmedetomidine. Clinical Trial Registration https://www.chictr.org.cn/showproj.html?proj=180658 .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Anesthesiology, Fuyang People's Hospital, Fuyang, China.
- Department of Anesthesiology, Children's Hospital of Anhui Province, Hefei, China.
Zitieren
APA
Dai, C., Zhao, X., Li, A., Zhang, X., Wang, P., Zhang, Y., & Wu, Y. (2025). Comparative evaluation of intravenous versus intranasal dexmedetomidine on emergence delirium and hemodynamics in pediatric patients undergoing adenotonsillectomy: a randomized controlled trial. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1543344
Vancouver
Dai C, Zhao X, Li A, Zhang X, Wang P, Zhang Y, et al. Comparative evaluation of intravenous versus intranasal dexmedetomidine on emergence delirium and hemodynamics in pediatric patients undergoing adenotonsillectomy: a randomized controlled trial. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1543344
BibTeX
@article{Dai2025,
author = {Dai, Chenxu and Zhao, Xuemei and Li, Aoxue and Zhang, Xuedong and Wang, Penglei and Zhang, Ye and Wu, Yun},
title = {Comparative evaluation of intravenous versus intranasal dexmedetomidine on emergence delirium and hemodynamics in pediatric patients undergoing adenotonsillectomy: a randomized controlled trial},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1543344}
}
EUVIMED